Skip to main content
. 2018 Aug 17;8:12306. doi: 10.1038/s41598-018-30710-4

Table 1.

Characteristics and treatment factors of patients.

Variables Strata Hypofractionated RT n=26 Conventional RT n = 46 p-value
No. or Median (range) (%) No. or Median (range) (%)
Age 51 (39–75) 54 (35–76) 0.61
Primary site Right 12 (43%) 19 (40%) 0.87
Left 14 (50%) 27 (57%)
Histology IDC 19 (70%) 31 (67%) 0.72
DCIS 6 (22%) 11 (24%)
Other 1 (4%) 4 (9%)
pT category is 6 (22%) 11 (24%) 0.68
1 16 (59%) 22 (48%)
2 4 (15%) 11 (24%)
3 0 (0%) 1 (2%)
4 0 (0%) 1 (2%)
pN category 0 24 (89%) 35 (76%) 0.16
1- 2 (7%) 11 (24%)
Chemotherapy Yes 7 (27%) 15 (33%) 0.61
No 19 (73%) 31 (67%)
Hormonal therapy Yes 9 (35%) 13 (28%) 0.57
No 17 (65%) 33 (72%)
Examined fraction Even fraction 2nd, 4th, 6th. 9 (35%) 13 (28%) 0.76
Odds fraction 1st, 3rd, 5th 17 (65%) 33 (72%)
Maximal dose (Gy) 46.4 ± 2.82 53.9 ± 1.7 <0.0001

IDC: invasive ductal carcinoma, DCIS; ductal carcinoma in situ.